4. S1 Episode 4: A review of Cabenuva®, an antiretroviral agent for HIV.

The Canadian Breakpoint por Dr. Rupeena Purewal

Notas del episodio

Dr. Rupeena Purewal invites special guest Saskatoon pharmacist Carley Pozniak to review Cabenuva®, an antiretroviral agent for HIV. Cabenuva® (Cabotegravir Extended Release Injectable Suspension) has been approved in 2020 for medical use in Canada.

Palabras clave
cabenuva